RP Bio Inc.

₩5,200As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:314140Healthcare
Country South Korea
PE (Fwd) •••
TSR 4Y CAGR (23.41%)
Div yield 0.96%
ROE 6.07%
Pharmaceutical Preparations
Beta (5Y) 0.48
PE TTM 6.691
TSR TTM (26.47%)
Mkt cap ₩45.07B
ROIC 6.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,019
15.76%
(60.22%)
Hold 3|0|5|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
64.77
66.47
73.38
81.00
1.08%
(4.10%)
9.65%
21.91%
Revenue₩B
4.543
4.687
4.843
5.121
2.85%
5.61%
9.65%
10.17%
Peers (US$33.23M)
Cap (US$)
PE
33.17M
—
31.33M
11.57x
Capital
TTM
5Y
10Y
Leveragex
1.827
0.351
0.306
EBIT/Intx
0.594
2.784
2.034
Own earn%
(10.51)
(108.77)
(98.77)
Sh yield%
23.41
46.20
43.43
Owners
Insiders/Inst%
0.72
55.69
Short interest%
2.46
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
9–17
$1 testx
−0.1
Incr. ROIC%
2